Acute 0 5 0 5 O
urinary 6 13 6 13 B-chronic_disease
tract 14 19 14 19 I-chronic_disease
infection 20 29 20 29 I-chronic_disease

Gleason 0 7 30 37 B-clinical_variable
Score 8 13 38 43 I-clinical_variable
â‰¤ 14 15 44 45 O
7 16 17 46 47 B-upper_bound

If 0 2 48 50 O
the 3 6 51 54 O
standard 7 15 55 63 B-treatment
biopsy 16 22 64 70 I-treatment
cores 23 28 71 76 O
are 29 32 77 80 O
positive 33 41 81 89 O
, 41 42 89 90 O
they 43 47 91 95 O
must 48 52 96 100 O
be 53 55 101 103 O
from 56 60 104 108 O
the 61 64 109 112 O
same 65 69 113 117 O
location 70 78 118 126 O
in 79 81 127 129 O
the 82 85 130 133 O
prostate 86 94 134 142 O
as 95 97 143 145 O
MR 98 100 146 148 O
lesion 101 107 149 155 O
was 108 111 156 159 O
biopsied 112 120 160 168 O
and 121 124 169 172 O
proven 125 131 173 179 O
to 132 134 180 182 O
be 135 137 183 185 O
cancerous 138 147 186 195 O

Lower 0 5 196 201 B-chronic_disease
urinary 6 13 202 209 I-chronic_disease
tract 14 19 210 215 I-chronic_disease
symptoms 20 28 216 224 I-chronic_disease
defined 29 36 225 232 O
by 37 39 233 235 O
International 40 53 236 249 B-clinical_variable
Prostate 54 62 250 258 I-clinical_variable
symptom 63 70 259 266 I-clinical_variable
score 71 76 267 272 I-clinical_variable
( 77 78 273 274 I-clinical_variable
IPSS 78 82 274 278 I-clinical_variable
) 82 83 278 279 I-clinical_variable
> 84 85 280 281 O
20 86 88 282 284 B-lower_bound

Prior 0 5 285 290 O
MRI 6 9 291 294 O
results 10 17 295 302 O
dated 18 23 303 308 O
within 24 30 309 315 O
120 31 34 316 319 B-upper_bound
days 35 39 320 324 I-upper_bound
prior 40 45 325 330 I-upper_bound
to 46 48 331 333 O
ablation 49 57 334 342 B-treatment

Prostate 0 8 343 351 B-cancer
cancer 9 15 352 358 I-cancer
is 16 18 359 361 O
diagnosed 19 28 362 371 O
by 29 31 372 374 O
MR 32 34 375 377 B-treatment
image 35 40 378 383 I-treatment
guided 41 47 384 390 I-treatment
biopsies 48 56 391 399 I-treatment

active 0 6 400 406 B-chronic_disease
bacterial 7 16 407 416 I-chronic_disease
infection 17 26 417 426 I-chronic_disease

acute 0 5 427 432 B-chronic_disease
or 6 8 433 435 I-chronic_disease
chronic 9 16 436 443 I-chronic_disease
hepatic 17 24 444 451 I-chronic_disease
dysfunction 25 36 452 463 I-chronic_disease
as 37 39 464 466 O
evidenced 40 49 467 476 O
by 50 52 477 479 O
clinically 53 63 480 490 O
significant 64 75 491 502 O
abnormalities 76 89 503 516 O
in 90 92 517 519 O
albumin 93 100 520 527 B-clinical_variable
, 100 101 527 528 O
total 102 107 529 534 O
protein 108 115 535 542 B-clinical_variable
, 115 116 542 543 O
or 117 119 544 546 O
prothrombin 120 131 547 558 B-clinical_variable
time 132 136 559 563 I-clinical_variable
, 136 137 563 564 O
or 138 140 565 567 O
evidence 141 149 568 576 O
of 150 152 577 579 O
hepatic 153 160 580 587 O
injury 161 167 588 594 O
with 168 172 595 599 O
clinically 173 183 600 610 O
important 184 193 611 620 O
( 194 195 621 622 O
> 195 196 622 623 O
grade 197 202 624 629 B-lower_bound
1 203 204 630 631 I-lower_bound
) 204 205 631 632 O
changes 206 213 633 640 O
in 214 216 641 643 O
AST 217 220 644 647 B-clinical_variable
, 220 221 647 648 O
ALT 222 225 649 652 B-clinical_variable
, 225 226 652 653 O
ALP 227 230 654 657 B-clinical_variable
, 230 231 657 658 O
bilirubin 232 241 659 668 B-clinical_variable
, 241 242 668 669 O
or 243 245 670 672 O
GGT 246 249 673 676 B-clinical_variable
values 250 256 677 683 O

documented 0 10 684 694 O
histological 11 23 695 707 O
or 24 26 708 710 O
cytological 27 38 711 722 O
evidence 39 47 723 731 O
of 48 50 732 734 O
tumor(s 51 58 735 742 B-cancer
) 58 59 742 743 I-cancer
of 60 62 744 746 I-cancer
the 63 66 747 750 I-cancer
prostate 67 75 751 759 I-cancer

extra 0 5 760 765 B-treatment
capsular 6 14 766 774 I-treatment

mental 0 6 775 781 B-chronic_disease
illness 7 14 782 789 I-chronic_disease

metastatic 0 10 790 800 B-chronic_disease
disease 11 18 801 808 I-chronic_disease

received 0 8 809 817 O
investigational 9 24 818 833 B-treatment
therapy 25 32 834 841 I-treatment
within 33 39 842 848 O
a 40 41 849 850 O
period 42 48 851 857 O
of 49 51 858 860 O
5 52 53 861 862 B-upper_bound
half 54 58 863 867 I-upper_bound
- 58 59 867 868 I-upper_bound
lives 59 64 868 873 I-upper_bound
of 65 67 874 876 O
the 68 71 877 880 O
investigational 72 87 881 896 O
therapy 88 95 897 904 O
in 96 98 905 907 O
question 99 107 908 916 O
prior 108 113 917 922 O
to 114 116 923 925 O
the 117 120 926 929 O
day 121 124 930 933 O
of 125 127 934 936 O
dosing 128 134 937 943 O
with 135 139 944 948 O
the 140 143 949 952 O
PEGylated 144 153 953 962 O
AuroShell 154 163 963 972 O
particles 164 173 973 982 O

renal 0 5 983 988 B-chronic_disease
insufficiency 6 19 989 1002 I-chronic_disease
with 20 24 1003 1007 O
an 25 27 1008 1010 O
estimated 28 37 1011 1020 B-clinical_variable
glomerular 38 48 1021 1031 I-clinical_variable
filtration 49 59 1032 1042 I-clinical_variable
( 60 61 1043 1044 I-clinical_variable
EGF 61 64 1044 1047 I-clinical_variable
) 64 65 1047 1048 I-clinical_variable
< 66 67 1049 1050 O
= 67 68 1050 1051 O
30 69 71 1052 1054 B-upper_bound

seminal 0 7 1055 1062 B-cancer
vesicle 8 15 1063 1070 I-cancer
invasion 16 24 1071 1079 I-cancer

treatment 0 9 1080 1089 O
for 10 13 1090 1093 O
prostate 14 22 1094 1102 B-cancer
cancer 23 29 1103 1109 I-cancer

uncontrolled 0 12 1110 1122 O
coagulopathies 13 27 1123 1137 B-chronic_disease
who 28 31 1138 1141 O
are 32 35 1142 1145 O
at 36 38 1146 1148 O
increased 39 48 1149 1158 O
risk 49 53 1159 1163 O
of 54 56 1164 1166 O
bleeding 57 65 1167 1175 O

